20.49 USD
▲-0.85+2.60%
盘后 19.85 -0.60%
2026-08-03
市值
$1.83B
市盈率
—
EPS
-16.86
股息率
—
52 周区间
16.25 – 27.00
成交量
136.92K
Beta
—
目标价
43.50
52W 低 16.2552W 高 27.00
价格走势
公司简介
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking. The...